๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Compound trial record
Trackers Drugs Trial finder
Compound · clinical trials

Nucleos(t)ide Analogues

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 2 trials in our China register that name Nucleos(t)ide Analogues as an intervention. Synced 24 Sep 2026
2Trials tracked
0Recruiting now
1Lead sponsor
1Country register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 โ€” Top 14 finalist
Compiled from ClinicalTrials.gov registry records ยท Last verified ยท Editorial standards

Nucleos(t)ide Analogues is named as a drug or biological intervention in 2 clinical trials in our China trial register, none of which are currently recruiting. The lead sponsor is Beijing 302 Hospital. Registered phases: Observational and Not applicable. Conditions studied include HBV; Chronic Hepatitis b; Chronic Hepatitis B.

01

Clinical trials of Nucleos(t)ide Analogues

2 trials
NCT IDStudyPhaseStatusLead sponsorRegister
NCT06926647 A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B (ClinicalTrials.gov ↗)
HBV, Chronic Hepatitis b
Observational Not yet open Beijing 302 Hospital China
NCT07809165 Sequential PD-1 Antibody and Pegylated Interferon Therapy for Nucleos(t)Ide Analogue-suppressed Chronic Hepatitis B (ClinicalTrials.gov ↗)
Chronic Hepatitis B
Not applicable Not yet open Beijing 302 Hospital China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied

3 conditions
Condition (as registered)Trials
HBV1
Chronic Hepatitis b1
Chronic Hepatitis B1
03

Sponsors

lead sponsor per trial
Lead sponsorTrials
Beijing 302 Hospital2
04

Trials by country register

RegisterNucleos(t)ide Analogues trials
Clinical trials in China2

A trial with sites in more than one country appears in each of those registers.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records โ€” it is not written from memory, and nothing here describes how Nucleos(t)ide Analogues works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Nucleos(t)ide Analogues (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician โ€” our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us โ€” we correct promptly and log it.